loading
前日終値:
$0.7778
開ける:
$0.7102
24時間の取引高:
2.89M
Relative Volume:
2.51
時価総額:
$11.13M
収益:
-
当期純損益:
$-16.60M
株価収益率:
-0.7093
EPS:
-0.89
ネットキャッシュフロー:
$-23.48M
1週間 パフォーマンス:
-21.18%
1か月 パフォーマンス:
-78.25%
6か月 パフォーマンス:
-84.37%
1年 パフォーマンス:
-93.08%
1日の値動き範囲:
Value
$0.61
$0.7444
1週間の範囲:
Value
$0.61
$0.8099
52週間の値動き範囲:
Value
$0.61
$29.40

Briacell Therapeutics Corp Stock (BCTX) Company Profile

Name
名前
Briacell Therapeutics Corp
Name
セクター
Healthcare (1166)
Name
電話
(604) 921-1810
Name
住所
3RD FLOOR, BELLEVUE CENTRE, 235-15TH STR, WEST VANCOUVER
Name
職員
12
Name
Twitter
Name
次回の収益日
2024-10-28
Name
最新のSEC提出書
Name
BCTX's Discussions on Twitter

BCTX を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
BCTX
Briacell Therapeutics Corp
0.6344 13.65M 0 -16.60M -23.48M -0.89
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
384.84 96.11B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
552.70 60.40B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
423.31 54.91B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
ARGX
Argen X Se Adr
672.26 41.30B 3.05B 1.28B -614.78M 19.58
Biotechnology icon
ONC
Beone Medicines Ltd Adr
297.13 33.25B 3.81B -644.79M -669.77M -6.24

Briacell Therapeutics Corp Stock (BCTX) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2022-02-14 開始されました H.C. Wainwright Buy

Briacell Therapeutics Corp (BCTX) 最新ニュース

pulisher
Aug 05, 2025

BriaCell Announces Share Consolidation to Maintain Nasdaq Compliance - TipRanks

Aug 05, 2025
pulisher
Aug 05, 2025

BriaCell Sets August 25 for Major 10:1 Share Consolidation: What Shareholders Must Know - Stock Titan

Aug 05, 2025
pulisher
Aug 05, 2025

BriaCell Announces Proposed Effective Date of Share Consolidation - GlobeNewswire

Aug 05, 2025
pulisher
Aug 05, 2025

My Honest Opinion of Energy Transfer Stock - The Globe and Mail

Aug 05, 2025
pulisher
Aug 05, 2025

Simon Property Reports Strong Q2 2025 Financial Results - The Globe and Mail

Aug 05, 2025
pulisher
Aug 03, 2025

What institutional investors are buying BriaCell Therapeutics Corp. Equity Warrant stockUnlock powerful stock screening techniques - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

How does BriaCell Therapeutics Corp. compare to its industry peersDiscover high-impact investment opportunities - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

How does BriaCell Therapeutics Corp. Equity Warrant generate profit in a changing economySuperior risk-adjusted returns - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

(BCT) Technical Pivots with Risk Controls (BCT:CA) - news.stocktradersdaily.com

Aug 03, 2025
pulisher
Aug 03, 2025

What institutional investors are buying BriaCell Therapeutics Corp. stockDiscover the next big stock winners - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What makes BriaCell Therapeutics Corp. stock price move sharplyCapitalize on emerging trends for profits - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

How volatile is BriaCell Therapeutics Corp. Equity Warrant stock compared to the marketMassive portfolio appreciation - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

BriaCell Therapeutics Corp. Equity Warrant Stock Analysis and ForecastGet daily updates on promising stocks - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

How does BriaCell Therapeutics Corp. Equity Warrant compare to its industry peersHigh-octane gains - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What makes BriaCell Therapeutics Corp. Equity Warrant stock price move sharplyUnlock powerful market insights for success - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What drives BriaCell Therapeutics Corp. Equity Warrant stock priceMaximize returns with data-driven strategies - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What is the dividend policy of BriaCell Therapeutics Corp. Equity Warrant stockMaximize gains with expert analysis - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

Published on: 2025-08-03 12:02:14 - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What is the risk reward ratio of investing in BriaCell Therapeutics Corp. Equity Warrant stockAchieve consistent double-digit returns - Jammu Links News

Aug 03, 2025
pulisher
Aug 02, 2025

Should I hold or sell BriaCell Therapeutics Corp. Equity Warrant stock in 2025Tremendous return rates - Jammu Links News

Aug 02, 2025
pulisher
Aug 02, 2025

What catalysts could drive BriaCell Therapeutics Corp. Equity Warrant stock higher in 2025Invest smarter with comprehensive market analysis - Jammu Links News

Aug 02, 2025
pulisher
Aug 02, 2025

How does BriaCell Therapeutics Corp. generate profit in a changing economyProven strategies for superior portfolio growth - Jammu Links News

Aug 02, 2025
pulisher
Aug 02, 2025

What catalysts could drive BriaCell Therapeutics Corp. stock higher in 2025Sky-high return potential - Jammu Links News

Aug 02, 2025
pulisher
Aug 02, 2025

Is BriaCell Therapeutics Corp. Equity Warrant stock overvalued or undervaluedRapid portfolio appreciation - Jammu Links News

Aug 02, 2025
pulisher
Aug 02, 2025

Is it the right time to buy BriaCell Therapeutics Corp. Equity Warrant stockDouble-digit growth - Jammu Links News

Aug 02, 2025
pulisher
Aug 02, 2025

Off-market insider buying at Atico Mining (ATY) - The Globe and Mail

Aug 02, 2025
pulisher
Aug 01, 2025

BriaCell Therapeutics Corp. Recovery Hinges on Volume BreakoutWeekly Setup With 3x Return Potential Published - metal.it

Aug 01, 2025
pulisher
Aug 01, 2025

Is BriaCell Therapeutics Corp. a growth stock or a value stockPre Market Review For Consistent Profits - Jammu Links News

Aug 01, 2025
pulisher
Jul 31, 2025

BriaCell Expands Phase 3 Breast Cancer Study with UCLA Health Partnership - TipRanks

Jul 31, 2025
pulisher
Jul 31, 2025

UCLA Health joins BriaCell’s phase 3 breast cancer study By Investing.com - Investing.com Nigeria

Jul 31, 2025
pulisher
Jul 31, 2025

UCLA Health joins BriaCell’s phase 3 breast cancer study - Investing.com

Jul 31, 2025
pulisher
Jul 31, 2025

BriaCell Adds UCLA Health as Key Site in Pivotal Phase 3 Breast Cancer Study - GlobeNewswire

Jul 31, 2025
pulisher
Jul 31, 2025

FDA Fast-Tracked: UCLA Health to Test BriaCell's Novel Breast Cancer Immunotherapy in Pivotal Phase 3 Trial - Stock Titan

Jul 31, 2025
pulisher
Jul 31, 2025

Foraco International reports Q2 2025 - The Globe and Mail

Jul 31, 2025
pulisher
Jul 30, 2025

WALSH PURE SPREADER -Pure Hedge Division - The Globe and Mail

Jul 30, 2025
pulisher
Jul 30, 2025

BriaCell granted New Zealand patent for cancer immunotherapy method By Investing.com - Investing.com South Africa

Jul 30, 2025
pulisher
Jul 30, 2025

BriaCell granted New Zealand patent for cancer immunotherapy method - Investing.com

Jul 30, 2025
pulisher
Jul 30, 2025

BriaCell Awarded New Zealand Patent for its Whole Cell Technology - GlobeNewswire

Jul 30, 2025
pulisher
Jul 30, 2025

Why BriaCell Therapeutics Corp. Equity Warrant stock attracts strong analyst attentionInvestment Playbook for Growing Markets Shared - metal.it

Jul 30, 2025
pulisher
Jul 30, 2025

BriaCell Secures New Zealand Patent for Cancer Immunotherapy - TipRanks

Jul 30, 2025
pulisher
Jul 30, 2025

BriaCell Secures Game-Changing Cancer Immunotherapy Patent: Breakthrough in Personalized Treatment - Stock Titan

Jul 30, 2025
pulisher
Jul 30, 2025

Published on: 2025-07-30 10:30:41 - metal.it

Jul 30, 2025
pulisher
Jul 30, 2025

BriaCell Therapeutics Files Patent for Cancer Treatment Platform - AInvest

Jul 30, 2025
pulisher
Jul 29, 2025

Is BriaCell Therapeutics Corp. Equity Warrant a Top Dividend Stock to Watch in 2025 - metal.it

Jul 29, 2025
pulisher
Jul 29, 2025

BriaCell’s Subsidiary, BriaPro, Files Patent Application for Immuno-Oncology Platform with Novel Multitargeting Agents - GlobeNewswire

Jul 29, 2025
pulisher
Jul 29, 2025

BriaCell Therapeutics Corp. Recovery Linked to Earnings SurpriseDaily Momentum Screener With Alerts Launched - metal.it

Jul 29, 2025
pulisher
Jul 29, 2025

Published on: 2025-07-29 17:12:14 - metal.it

Jul 29, 2025
pulisher
Jul 29, 2025

BriaCell Therapeutics Corp. Equity Warrant Recovers — But Is It SustainableReal Time Trade Opportunity Alerts Monitor Market Surges - metal.it

Jul 29, 2025
pulisher
Jul 29, 2025

BriaCell’s BriaPro Files Patent for Innovative Cancer Treatment Platform - TipRanks

Jul 29, 2025
pulisher
Jul 29, 2025

Revolutionary Cancer Treatment: BriaCell's New Platform Targets 5 Major Cancer Types Simultaneously - Stock Titan

Jul 29, 2025
pulisher
Jul 29, 2025

Why did BCTX report zero EPS for Q3 2023? - AInvest

Jul 29, 2025

Briacell Therapeutics Corp (BCTX) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$77.07
price down icon 0.83%
$37.26
price down icon 1.82%
$110.61
price down icon 1.00%
$28.19
price down icon 3.12%
$109.89
price down icon 1.06%
biotechnology ONC
$297.19
price down icon 3.52%
大文字化:     |  ボリューム (24 時間):